FI932053A0 - Syntetiska glykonkonjugatantigener av lipid a foer att anvaendas i vacciner - Google Patents

Syntetiska glykonkonjugatantigener av lipid a foer att anvaendas i vacciner

Info

Publication number
FI932053A0
FI932053A0 FI932053A FI932053A FI932053A0 FI 932053 A0 FI932053 A0 FI 932053A0 FI 932053 A FI932053 A FI 932053A FI 932053 A FI932053 A FI 932053A FI 932053 A0 FI932053 A0 FI 932053A0
Authority
FI
Finland
Prior art keywords
synthetic
vacciner
glyconkjjugatantigener
lipid
foer att
Prior art date
Application number
FI932053A
Other languages
English (en)
Other versions
FI932053A (fi
Inventor
Massimo Porro
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI932053A0 publication Critical patent/FI932053A0/fi
Publication of FI932053A publication Critical patent/FI932053A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
FI932053A 1992-05-07 1993-05-06 Syntetiska glykonkonjugatantigener av lipid a foer att anvaendas i vacciner FI932053A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87940392A 1992-05-07 1992-05-07

Publications (2)

Publication Number Publication Date
FI932053A0 true FI932053A0 (fi) 1993-05-06
FI932053A FI932053A (fi) 1993-11-08

Family

ID=25374087

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932053A FI932053A (fi) 1992-05-07 1993-05-06 Syntetiska glykonkonjugatantigener av lipid a foer att anvaendas i vacciner

Country Status (14)

Country Link
EP (1) EP0570682B1 (fi)
JP (1) JPH0641200A (fi)
KR (1) KR930023369A (fi)
AT (1) ATE155790T1 (fi)
AU (1) AU664609B2 (fi)
CA (1) CA2095588A1 (fi)
DE (1) DE69312391T2 (fi)
DK (1) DK0570682T3 (fi)
ES (1) ES2104984T3 (fi)
FI (1) FI932053A (fi)
GR (1) GR3024706T3 (fi)
IL (1) IL105605A0 (fi)
NO (1) NO180234C (fi)
SG (1) SG47582A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008214256A (ja) * 2007-03-02 2008-09-18 Yaizu Suisankagaku Industry Co Ltd 双頭型配糖化合物の製造方法及び双頭型配糖化合物並びに該双頭型配糖化合物を含有する糖鎖認識タンパク質結合剤
EP2326671A4 (en) * 2008-09-05 2012-10-03 Ca Nat Research Council LPS BASED VACCINES
JP2019513137A (ja) 2016-03-30 2019-05-23 アユヴィス リサーチ インク.Ayuvis Research, Inc. 新規組成物及び治療方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
AU651319B2 (en) * 1989-07-27 1994-07-21 Univax Biologics Incorporated Lipid A analog/immunogenic carrier conjugates and the use thereof as vaccines

Also Published As

Publication number Publication date
AU664609B2 (en) 1995-11-23
EP0570682B1 (en) 1997-07-23
NO931655L (no) 1993-11-08
GR3024706T3 (en) 1997-12-31
AU3841993A (en) 1993-11-11
EP0570682A1 (en) 1993-11-24
CA2095588A1 (en) 1993-11-08
ATE155790T1 (de) 1997-08-15
NO180234C (no) 1997-03-12
JPH0641200A (ja) 1994-02-15
ES2104984T3 (es) 1997-10-16
KR930023369A (ko) 1993-12-18
DE69312391D1 (de) 1997-08-28
DK0570682T3 (da) 1998-02-16
SG47582A1 (en) 1998-04-17
DE69312391T2 (de) 1997-12-11
FI932053A (fi) 1993-11-08
NO931655D0 (no) 1993-05-06
NO180234B (no) 1996-12-02
IL105605A0 (en) 1993-09-22

Similar Documents

Publication Publication Date Title
DE69126606D1 (de) Vakzine
ES2092306T3 (es) Adyuvante para vacunas.
EP0306524A4 (en) ANTI-DETERMINANTS DETECTED BY ANTIBODIES PRODUCED BY USING A RESTRICTED NUMBER OF ANTIGENT PRESENTING PATHOGENIC AGENTS OR DERIVATIVES.
FI862868A (fi) Nya aminofenoler och deras anvaendning i oxiderbara haorfaergmedel.
TW222000B (fi)
PT87065A (pt) Process for the preparation of a vaccine against pasteurellosis
FI932053A0 (fi) Syntetiska glykonkonjugatantigener av lipid a foer att anvaendas i vacciner
ITRM910385A1 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni
NO911262L (no) Lettvektsement for anvendelse i omgivelser med hoeyt trykk.
FI923348A (fi) Laekemedel och foerfaranden foer kelandering av aids och aids-relaterade komplex (arc) med anvaendning av kolhydratantigener och antikroppar mot kolhydrater.
IT1242974B (it) Gruppo impaccatore con doppio magnete
FI922710A0 (fi) Eliminering av aktiverade lymfocyter.
FI911126A (fi) Organokupraattimenetelmä kefprotsilin valmistamiseksi
FI913475A (fi) Klass ii protein med immunologiska baerar- och foerstaerkningsegenskaper fraon yttermembranen i neisseria meningitidis och vaccin innehaollande detta.
FR2659650B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphnylene diamines.
RU1805045C (ru) Устройство дл креплени закладной детали к форме
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
SE8703453D0 (sv) Preparation innehallande hogmolekylert bakteriellt protein, antikroppspreparation riktad deremot samt preparationernas anvendning
SE9202538L (sv) Foerfarande foer fosfatfaellning med jaernhydroxid
IS3656A7 (is) Bóluefni gegn heilahimnubólgu
IT223982Z2 (it) Borsa per documenti o simili
DK249690D0 (da) Beholder med laag
IT9021453A0 (it) Manufatto imbottito per arredamento
KR920000972U (ko) 봄 베
DK30992A (da) Baerbar geofysisk energikilde

Legal Events

Date Code Title Description
FD Application lapsed